Mirum Pharmaceuticals, Inc.MIRMNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$9.33M
↑ 113% above average
Average (6y)
$-70.10M
Historical baseline
Range
High:$9.33M
Low:$-151.78M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $9.33M | +110.2% |
| 2023 | $-91.05M | +24.4% |
| 2022 | $-120.41M | +20.7% |
| 2021 | $-151.78M | -70.0% |
| 2020 | $-89.30M | -125.3% |
| 2019 | $-39.64M | -403.5% |
| 2018 | $-7.87M | - |